NewAmsterdam Pharma (NAMS) FCF Margin Growth (3y) (2026)
NewAmsterdam Pharma (NAMS) FCF Margin Growth (3y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | - |
| 10 | NewAmsterdam Pharma | 3.77 Bn | 3.77 Bn | - | -63,862.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63,862.00 |